Position in AMGN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$347,635
+$23,933 QoQ
Shares Held
960
+4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,448
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. AMGN ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
This page
|
960 | $347,635 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347,635 | 960 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $323,702 | 920 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $306,034 | 935 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $269,783 | 956 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $249,613 | 894 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $215,904 | 693 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $224,411 | 861 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $208,792 | 648 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $210,591 | 674 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $5,771,411 | 20,299 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $5,455,386 | 18,941 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,647,129 | 17,291 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $3,607,158 | 16,247 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $3,970,985 | 16,426 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $4,355,884 | 16,585 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $3,789,650 | 16,813 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,067,002 | 16,716 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,357,354 | 18,019 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $4,048,785 | 17,997 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,828,763 | 18,005 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $4,419,675 | 18,132 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,416,128 | 17,749 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,940,139 | 17,137 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $4,678,068 | 18,406 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,194,062 | 17,782 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,210,635 | 15,837 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||